Delivery Order SPE2DR25D3301-SPE2DR26F20KM
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 2, 2026, for the supply of Darzalex 100 mg/5 ml vials with a ceiling value of $1,378.59 under firm fixed price terms. The order is scheduled for completion by January 26, 2026, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order was competitively awarded without set-aside designation and represents a child contract under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order valued at $5,481.75 to AmerisourceBergen Drug Corp for the supply of Darzalex 400 mg/20 ml vials. This firm fixed-price, competitively awarded delivery order was issued on January 2, 2026, with an ultimate completion date of January 26, 2026. The product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $37,813.26 delivery order to AmerisourceBergen Drug Corp on November 26, 2025, for the supply of Darzalex Faspro (daratumumab) 1,800 mg-30,000 IU in 15 mL vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, scheduled for completion by December 18, 2025. The work will be performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Darzalex Faspro 1,800mg/30,000 15ml pharmaceutical product. This firm fixed-price delivery order, valued at $239,208.40, represents a competitively awarded, non-set-aside contract with a completion deadline of October 17, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $5,060.79 to AmerisourceBergen Drug Corp for the supply of DARZALEX 400 mg/20 mL vials. This competitively awarded, firm fixed-price delivery order has an ultimate completion date of August 12, 2025, and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The award carries no set-aside designation, indicating the contract was competed among qualified vendors in the open market. This delivery order is issued...
- The Defense Logistics Agency awarded a $6,747.72 firm fixed price delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of DARZALEX 400 mg/20 ml vials. The contract, which is scheduled for completion by November 17, 2025, represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform delivery from its corporate office location at the same address. This delivery order falls under the company's larger...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Darzalex Faspro 1,800mg-30,000 15mL pharmaceutical product at a firm fixed price of $6,525.77. This non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order carries an ultimate completion date of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product. This firm fixed price delivery order is valued at $119,604.20 and is scheduled for completion by October 9, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation and operates as a child...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide the drug DARZALEX 400 MG/20 ML VIAL 20ML. The $15,511.12 contract has an ultimate completion date of April 29, 2024. AmerisourceBergen Drug Corp is the prime contractor and no set-aside designation was used. The contract was awarded under a larger indefinite delivery contract (IDC) with a potential value of...
- The Defense Logistics Agency (DLA) awarded a $107,643.78 delivery order to AmerisourceBergen Drug Corp on September 29, 2025, for the supply of Darzalex Faspro 1,800mg-30,000 15ml pharmaceutical product, with an ultimate completion date of October 21, 2025. This is a firm fixed price contract with no set-aside designation, competitively awarded to the prime contractor at its corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract issued under...
- SPE2DR25D3301Indefinite Delivery Contract
- SPE2DR25D3301-SPE2DR26F20KMDelivery Order
The Defense Logistics Agency awarded a $16,445.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of Darzalex 400 mg/20 mL vials. The contract, which represents a non-competitive set-aside delivery order, is scheduled for completion by January 29, 2026, with performance occurring at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical distributor serving the federal government's medical supply needs, particularly for military and veteran healthcare systems. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The parent company, Cencora, Inc., maintains the primary $999,999,999.00 IDC with DLA through December 31, 2031, which provides a comprehensive global pharmaceutical support vehicle enabling the supply of specialty medications, brand-name and generic drugs, vaccines, and medical supplies to military treatment facilities and other federal healthcare systems worldwide. The delivery of Darzalex, a specialty oncology medication, reflects AmerisourceBergen's role in supplying critical pharmaceutical products across multiple therapeutic domains to support Defense Health Agency programs and other government medical institutions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.4k | 1/6/26 |